about
Design, synthesis, and evaluation of orally active benzimidazoles and benzoxazoles as vascular endothelial growth factor-2 receptor tyrosine kinase inhibitorsNovel 2,3-dihydro-1,4-benzoxazines as potent and orally bioavailable inhibitors of tumor-driven angiogenesisEvaluation of a series of naphthamides as potent, orally active vascular endothelial growth factor receptor-2 tyrosine kinase inhibitorsDiscovery and optimization of triazolopyridazines as potent and selective inhibitors of the c-Met kinaseDiscovery and optimization of potent and selective triazolopyridazine series of c-Met inhibitorsDiscovery of triazine-benzimidazoles as selective inhibitors of mTORDiscovery of 2,4-bis-arylamino-1,3-pyrimidines as insulin-like growth factor-1 receptor (IGF-1R) inhibitorsDiscovery and optimization of a potent and selective triazolopyridinone series of c-Met inhibitorsDiscovery, Design, and Optimization of Isoxazole Azepine BET InhibitorsDiscovery of potent and selective 8-fluorotriazolopyridine c-Met inhibitorsDiscovery of (R)-6-(1-(8-Fluoro-6-(1-methyl-1H-pyrazol-4-yl)-[1,2,4]triazolo[4,3-a]pyridin-3-yl)ethyl)-3-(2-methoxyethoxy)-1,6-naphthyridin-5(6H)-one (AMG 337), a Potent and Selective Inhibitor of MET...Identification of a Benzoisoxazoloazepine Inhibitor (CPI-0610) of the Bromodomain and Extra-Terminal (BET) Family as a Candidate for Human Clinical TrialsIdentification of potent, selective KDM5 inhibitorsDesign and evaluation of 1,7-naphthyridones as novel KDM5 inhibitors
P50
Q27647166-78D34899-1CA4-491D-815B-E741B7ECA21CQ27649966-436739E1-C424-42F2-B5C1-7CB0694DA353Q27650017-BE79684F-09F8-4E4F-8D11-49A266034FDAQ27650405-3AF036E3-80F3-4038-94E2-7CE9914995FAQ27657743-F58D42B3-03A8-42E4-AC8F-BC69055A4049Q27666874-9E91DB50-206C-41CD-A5B8-D4620D1F6DBCQ27667002-2C6A1BA5-D938-4F27-91CE-EBFFFDB1E952Q27679149-EF806BBE-95A0-4C3B-BDFE-0AD2EF267F70Q27684210-67042A54-F589-4437-AEE3-61DC286004A2Q27698033-E065A54B-8139-4E09-A805-9137E04319D5Q27703733-05F55F28-BBA1-4A57-B0DE-2382D0FC5AA5Q27703736-DAE2A222-8D13-4CEC-9E11-5FE7086665BCQ27723125-3025161C-099A-4414-BDE9-837A2FFE0A1FQ27726213-86CE8565-8CF1-43A3-837D-28E8F8CCCDB3
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Jean-Christophe Harmange
@ast
Jean-Christophe Harmange
@en
Jean-Christophe Harmange
@es
Jean-Christophe Harmange
@nl
Jean-Christophe Harmange
@sl
type
label
Jean-Christophe Harmange
@ast
Jean-Christophe Harmange
@en
Jean-Christophe Harmange
@es
Jean-Christophe Harmange
@nl
Jean-Christophe Harmange
@sl
prefLabel
Jean-Christophe Harmange
@ast
Jean-Christophe Harmange
@en
Jean-Christophe Harmange
@es
Jean-Christophe Harmange
@nl
Jean-Christophe Harmange
@sl